2021-01-11,Lilly Rockets On Alzheimer's News  And 3 Other Highlights From Key Health Care Meeting
2021-01-11,bluebird bio to Spin Off Its Oncology Business
2021-01-11,Gene-Therapy Firm Bluebird Bio Is Spinning Off Its Cancer Programs
2021-01-11,Bluebird's stock is up 5% as it details plans to separate oncology and genetic disease businesses
2021-01-11,bluebird bio to Separate Oncology Business into Independent Company
2021-01-04,3 Top Biotech Buyout Candidates in 2021
2020-12-24,3 FDA Dates Biotech Investors Should Circle in 2021
2020-12-23,Here Are the 2 Best Biotech Stocks in This Multibillion-Dollar Industry
2020-12-21,Where Do Hedge Funds Stand On bluebird bio Inc (BLUE)?
2020-12-15,This Gene Therapy Stock Is Ablaze On Eli Lilly's $1.04 Billion Takeover
2020-12-13,ASH Annual Meeting: Drugmakers Battle for Multiple Myeloma
2020-12-12,"Watch Out bluebird bio, CRISPR Is on Your Heels"
2020-12-12,3 Stocks That Are Giving Their Investors Coal in Their Stockings
2020-12-10,Is CRISPR Therapeutics Heading for $170?
2020-12-08,The Latest Lap in Bluebirds and Crisprs Race to Cure Sickle Cell
2020-12-07,Treatment with Investigational LentiGlobin Gene Therapy for Sickle Cell Disease (bb1111) Results in Complete Elimination of SCD-Related Severe Vaso-Occlusive Events in Group C of Phase 1/2 HGB-206 Clinical Study Presented at 62nd Annual ASH Meeting
2020-12-07,Race for Multiple Myeloma Drugs Not Moving Stocks  Yet
2020-12-05,Long-Term Data for bluebird bios betibeglogene autotemcel (beti-cel) Gene Therapy Show Patients Across Ages and -thalassemia Genotypes Achieve Transfusion Independence and Remain Free from Transfusions Up to Six Years Presented at 62nd ASH Meeting
2020-12-05,"Bristol Myers Squibb and bluebird bio Present Data Highlighting Anti-BCMA CAR T Cell Therapy, Ide-cel, in Relapsed and Refractory Multiple Myeloma at ASH 2020"
2020-12-04,Bluebird (BLUE) Down 3.8% Since Last Earnings Report: Can It Rebound?
2020-12-04,New Results on Blood Disorder Treatments Are Coming. Watch These Stocks.
2020-12-04,Magenta Therapeutics and bluebird bio Announce a Phase 2 Clinical Trial Collaboration to Evaluate Magentas MGTA-145 for Mobilizing and Collecting Stem Cells in Adults and Adolescents with Sickle Cell Disease
2020-11-30,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of bluebird bio, Inc.  BLUE"
2020-11-28,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of bluebird bio, Inc. - BLUE"
2020-11-24,bluebird bio Announces Live Webcast to Review Clinical Data Presented at the American Society of Hematology (ASH) Annual Meeting
2020-11-23,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE"
2020-11-21,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE"
2020-11-18,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE"
2020-11-16,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE"
2020-11-14,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of bluebird bio, Inc. - BLUE"
2020-11-11,"SHAREHOLDER ALERT: Investigation of bluebird Announced by Holzer & Holzer, LLC"
2020-11-10,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE"
2020-11-10,bluebird bio Announces November Investor Events
2020-11-09,"Bronstein, Gewirtz & Grossman, LLC Notifies Investors of bluebird bio, Inc. (BLUE) Investigation"
2020-11-07,"bluebird bio, Inc. (NASDAQ:BLUE) Analysts Are Cutting Their Estimates: Here's What You Need To Know"
2020-11-06,Can bluebird bio Recover From Another Major Setback?
2020-11-05,Gene Therapy Stock Plunges On Unexpected Delay For Sickle Cell Drug
2020-11-05,Here's Why Bluebird's Shares Fell Out of the Nest Today
2020-11-05,Bluebird Bio Off on Delay in Sickle-Cell Treatment Submission
2020-11-05,Why Bluebird Bio's Stock Is Trading Lower Today
2020-11-05,Bluebird bio's stock plunges after submission delay of sickle cell disease treatment
2020-11-05,ROCE Insights For bluebird bio
2020-11-05,"The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping"
2020-11-05,bluebird bio to Present Data from Gene and Cell Therapy Programs During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition
2020-11-04,"Bluebird Bio (BLUE) Reports Q3 Loss, Lags Revenue Estimates"
2020-11-04,Why This Gene-Editing Player Just Outpaced Bullish Biotech Stocks
2020-11-04,bluebird bio Reports Third Quarter 2020 Financial Results and Highlights Operational Progress
2020-11-04,Why This Gene-Editing Player Just Outpaced Bullish Biotech Stocks
2020-11-03,Were These Hedge Funds Wrong About Buying bluebird bio Inc (BLUE)?
2020-10-22,Will Bluebird Bio (BLUE) Report Negative Q3 Earnings? What You Should Know
2020-10-20,Why This Bluebird Bio Analyst Sees Over 125% Upside Ahead
2020-10-11,"Here's What We Learned About The CEO Pay At bluebird bio, Inc. (NASDAQ:BLUE)"
2020-10-04,Got $500? Here Are 2 Stocks That Could Soar
2020-10-02,"bluebird bio Announces European Medicines Agencys Acceptance of Marketing Authorization Application (MAA) for elivaldogene autotemcel (eli-cel, Lenti-D) Gene Therapy for Cerebral Adrenoleukodystrophy (CALD)"
2020-09-28,bluebird bio to Present at Jefferies Cell Therapy Virtual Summit
2020-09-23,bluebird bios LentiGlobin for Sickle Cell Disease Gene Therapy (bb1111) Granted Priority Medicines (PRIME) Designation by European Medicines Agency
2020-09-22,"Bristol Myers, Bluebird Bio Blood Cancer Treatment Gets FDA Priority Review; BLUE Stock Up"
2020-09-22,FDA Accepts Application for Bristol-Myers Squibb and bluebird bio's Multiple Myeloma CAR-T Therapy
2020-09-22,"U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb and bluebird bio Application for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121)"
2020-09-09,Should I Buy bluebird bio Inc (BLUE)?
2020-09-09,Is bluebird bio Stock a Buy?
2020-09-04,Bluebird (BLUE) Down 7.8% Since Last Earnings Report: Can It Rebound?
2020-09-02,bluebird bio Announces September Investor Events
2020-08-29,"bluebird bio Presents New Results from Clinical Development Program of elivaldogene autotemcel (eli-cel, Lenti-D) Gene Therapy for Cerebral Adrenoleukodystrophy (CALD), Including Updated Long-Term Data, at the 46th Annual Meeting of the EBMT"
2020-08-17,"bluebird bio to Present New Data from Clinical Studies of elivaldogene autotemcel (eli-cel, Lenti-D) Gene Therapy for Cerebral Adrenoleukodystrophy (CALD) at the Virtual Edition of the 46th EBMT Annual Meeting"
2020-08-12,Companies Like bluebird bio (NASDAQ:BLUE) Are In A Position To Invest In Growth
2020-08-11,bluebird bio Appoints Denice Torres to Board of Directors
2020-08-06,Why Bluebird Bio's Stock Is Trading Higher Today
2020-08-05,"Bluebird Bio (BLUE) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-05,bluebird bio Reports Second Quarter 2020 Financial Results and Recent Operational Progress
2020-08-05,Why Earnings Season Could Be Great for bluebird bio (BLUE)
2020-07-31,bluebird bio Announces August Investor Event
2020-07-30,Bluebird Bio (BLUE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2020-07-29,"Bristol Myers Squibb and bluebird bio Announce Submission of Biologics License Application (BLA) to FDA for Idecabtagene Vicleucel (Ide-cel, bb2121) for Adults with Relapsed and Refractory Multiple Myeloma"
2020-07-25,Gene Therapy Companies Are Racing to Cure Sickle Cell. That Would Open the Door to Curing Dozens of Other Diseases.
2020-07-13,Were Hedge Funds Right About bluebird bio Inc (BLUE)?
2020-07-07,"How Much Of bluebird bio, Inc. (NASDAQ:BLUE) Do Institutions Own?"
2020-07-01,"Wall Street Has Given Up on These 2 Stocks, and That's a Huge Mistake"
2020-06-23,How bluebird bio (BLUE) Stock Stands Out in a Strong Industry
2020-06-22,Repare and Forma Shares Gobbled Up in IPO
2020-06-18,Edited Transcript of BLUE.OQ earnings conference call or presentation 11-May-20 12:00pm GMT
2020-06-16,Bluebird and Crispr Show Promise for Sickle-Cell Cures
2020-06-12,bluebird bio Reports Dramatic Improvement in Sickle Cell Patients with LentiGlobin Gene Therapy
2020-06-12,New Data Show Near Elimination of Sickle Cell Disease-Related Vaso-Occlusive Crises and Acute Chest Syndrome in Phase 1/2 Clinical Study of bluebird bios LentiGlobin Gene Therapy for Sickle Cell Disease at 25th EHA Congress
2020-06-12,Majority of Evaluable Patients Across Genotypes Achieve Transfusion Independence and Maintain It with Near-Normal Hemoglobin Levels in Phase 3 Studies of betibeglogene autotemcel (LentiGlobin for -thalassemia) Gene Therapy Presented at EHA Congress
2020-06-11,Better Buy: bluebird bio vs. Gilead Sciences
2020-06-10,Why Is Bluebird (BLUE) Up 17.4% Since Last Earnings Report?
2020-06-08,Here is What Hedge Funds Think About bluebird bio Inc (BLUE)
2020-06-05,"bluebird bio's Shares March Higher, Can It Continue?"
2020-06-04,Pliant Therapeutics Shares Have Climbed 44% Since This Week's IPO
2020-06-03,bluebird bio Announces That Its 2020 Annual Meeting of Stockholders Will Be Held in Virtual Format
2020-05-28,bluebird bio Announces Live Webcast of EHA Data Review and June Investor Events
2020-05-27,What Sanofi Might Buy With Its Regeneron Windfall
2020-05-25,Bluebird (BLUE) Upgraded to Buy: What Does It Mean for the Stock?
2020-05-22,FDA Mishaps Have Investors Asking Whats Going On With bluebird bio?
2020-05-19,8 Biotechs Tapping Secondary Markets for $3 Billion
2020-05-19,"Bluebird Prices New Shares At $55, Seeks To Raise $500 Million"
2020-05-18,bluebird bio Announces Pricing of Public Offering of Common Stock
2020-05-18,Coronavirus update: Global case tally reaches 4.8 million; Chinas Xi supports WHO-backed probe of origins of pandemic  once the crisis is over
2020-05-18,Bluebird Bio's stock falls after proposed public stock offering
